(MENAFN- Comserve) Shibuya-ku, Tokyo, Japan, Japan, Oct 14, 2021, 06:34 /Comserve / -- The global Biosensors market is segregated on the basis of Product as Nonwearable Biosensors and Wearable Biosensors.
The Global Biosensors Market is expected to grow by 2025 at a CAGR of 9.04%.
Biosensor may be device that is used to sense the concentration or presence of biological analyte, similar a biological structure or a microorganism. These sensors involve of a component that identifies the analyte & products a signal, a reader device and a signal transducer. Biosensors for determining blood metabolites like lactate, glucose, creatinine, and urea, using both optical and electrochemical methods of transduction, are being routinely used and commercially settled in the point of care testing, laboratories, and self-testing for glucose monitoring. They have applications in various segments in the healthcare industry. Furthermore, miniaturization of these biosensors has transformed the conventional testing scenario healthcare and in medical sectors. Medical biosensors are used to diagnose blood glucose monitoring, cholesterol testing, drug discovery, pregnancy testing systems and infectious diseases. These sensors are measured to be a vital tool in the monitoring and recognition of large variety medical situations such as cancer and diabetes.
The global Biosensors market is segregated on the basis of Product as Nonwearable Biosensors and Wearable Biosensors. Based on Application the global Biosensors market is segmented in Biodefense, Environmental Monitoring, Food & Beverages, POC, Home Diagnostics, and Research Lab. Based on Type the global Biosensors market is segmented in Sensor Patch and Embedded Device.
Request to Fill The Form To get Sample Copy of This Report:
Based on Technology, the global Biosensors market is segmented in Optical Biosensors, Piezoelectric Biosensors, Electrochemical Biosensors, Nanomechanical Biosensors, Thermal Biosensors, and Others.
The global Biosensors market report provides geographic analysis covering regions, such as North America, Europe, Asia-Pacific, and Rest of the World. The Biosensors market for each region is further segmented for major countries including the U.S., Canada, Germany, the U.K., France, Italy, China, India, Japan, Brazil, South Africa, and others.
Competitive Rivalry
Ercon Inc., LifeSensors, Nova Biomedical, ACON Laboratories, Inc., Pharmaco-Kinesis Corporation, Abbott Laboratories Inc., Hoffman-La Roche, Medtronic, Universal Biosensors, Siemens AG, and others are among the major players in the global Biosensors market. The companies are involved in several growth and expansion strategies to gain a competitive advantage. Industry participants also follow value chain integration with business operations in multiple stages of the value chain.
The Biosensors Market has been segmented as below:
Biosensors Market, By Product
Nonwearable Biosensors
Wearable Biosensors
Biosensors Market, By Application
Biodefense
Environmental Monitoring
Food & Beverages
POC
Home Diagnostics
Research Lab
Biosensors Market, By Type
Sensor Patch
Embedded Device
Biosensors Market, By Technology
Optical Biosensors
Piezoelectric Biosensors
Electrochemical Biosensors
Nanomechanical Biosensors
Thermal Biosensors
Others
Biosensors Market, By Region
North America
Europe
Asia-Pacific
Rest of the World
Biosensors Market, By Company
Ercon Inc.
LifeSensors
Nova Biomedical
ACON Laboratories, Inc.
Pharmaco-Kinesis Corporation
Abbott Laboratories Inc.
Hoffman-La Roche
Medtronic
Universal Biosensors
Siemens AG
LifeScan
Bayer Healthcare AG
Bio-Rad Laboratories, Inc.
Dowdupont Inc.
Sysmex Corporation
Biacore
Biosensors International Pte. Ltd.
The report covers:
Global Biosensors market sizes from 2015 to 2024, along with CAGR for 2018-2024
Market size comparison for 2017 vs 2024, with actual data for 2017, estimates for 2018 and forecast from 2019 to 2024
Global Biosensors market trends, covering comprehensive range of consumer trends & manufacturer trends
Value chain analysis covering participants from raw material suppliers to the downstream buyer in the global Biosensors market
Major market opportunities and challenges in forecast timeframe to be focused
Competitive landscape with analysis on competition pattern, portfolio comparisons, development trends and strategic management
Comprehensive company profiles of the key industry players
Report Scope:
The global Biosensors market report scope includes detailed study covering underlying factors influencing the industry trends.
The report covers analysis on regional and country level market dynamics. The scope also covers competitive overview providing company market shares along with company profiles for major revenue contributing companies.
The report scope includes detailed competitive outlook covering market shares and profiles key participants in the global Biosensors market share. Major industry players with significant revenue share include Ercon Inc., LifeSensors, Nova Biomedical, ACON Laboratories, Inc., Pharmaco-Kinesis Corporation, Abbott Laboratories Inc., Hoffman-La Roche, Medtronic, Universal Biosensors, Siemens AG, and others.
Reasons to Buy this Report:
Gain detailed insights on the Biosensors industry trends
Find complete analysis on the market status
Identify the Biosensors market opportunities and growth segments
Analyse competitive dynamics by evaluating business segments & product portfolios
Facilitate strategy planning and industry dynamics to enhance decision making
Some of the recent Developments in Biosensors market are as follows:
Nova Biomedical
04-2020: Nova Biomedical has declared the U.S. Food and Drug Administration has cleared its Stat Profile Prime Plus critical care blood gas analyzer for point-of-care use.
04-2020: Nova Biomedical is delighted to declare the introduction of the Stat EMS Basic blood testing system for ambulance and emergency care in CE mark countries. Stat EMS Basic measures fingerstick capillary lactate, glucose, ketone, hemoglobin, and hematocrit in six to 40 seconds with laboratory-quality results.
Medtronic
06-2020: Medtronic plc the global leader in medical technology, declared it has received CE Mark for a one-month dual antiplatelet therapy indication for high bleeding risk patients implanted with the Resolute Onyx Drug-Eluting Stent.
10-2019: Medtronic plc has declared it has received U.S. Food and Drug Administration approval to begin an early feasibility study for its Intrepi transcatheter mitral valve replacement system using a minimally-invasive transfemoral access approach.
The dynamic nature of business environment in the current global economy is raising the need amongst business professionals to update themselves with current situations in the market. To cater such needs, Shibuya Data Count provides market research reports to various business professionals across different industry verticals, such as healthcare & pharmaceutical, IT & telecom, chemicals and advanced materials, consumer goods & food, energy & power, manufacturing & construction, industrial automation & equipment and agriculture & allied activities amongst others.
MENAFN14102021004694010674ID1102972926
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.